Research And Markets Research And Markets

Summary: Insight Pharmaceuticals LLC Mar 12

  • ID: 2084035
  • March 2012
  • Standard & Poors
1 of 3

The ratings on Langhorne, Pa.-based Insight Pharmaceuticals LLC (Insight) reflect Standard & Poor's Ratings Services' opinion that the company's financial risk profile will remain "highly leveraged" (as our criteria define the term) as a result of its high debt burden relative to its size, and its aggressive financial policy. We believe Insight will maintain leverage consistent with ratios indicative of our highly leveraged financial profile over the next year. We expect the company will continue to maintain a "weak" business risk profile, based on Insight's continuing narrow business focus within the over-the-counter (OTC) consumer products segment, and ongoing lack of international diversity in its product lines. We believe Insight maintains a highly leveraged capital structure. Specifically, we estimate the pro...

Companies mentioned in this report are:
- Insight Pharmaceuticals LLC

Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine READ MORE >

Note: Product cover images may vary from those shown
2 of 3

- Insight Pharmaceuticals LLC

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown